BioStock Life Science Summit
biotech pharma diagnostics devices
Showcases & Networking
Save the date // Oct 20-21 // 2020
Medicon Village Lund Sweden
The Summit 2020
The Life Science Event of the Year
We proudly welcome you to the third annual BioStock Life Science Summit, where innovation and capital connect. Hosted at innovation super-cluster Medicon Village in Lund, the Summit is the Nordic region's premier meeting place for visionary entrepreneurs and investors, start-ups and proven industry leaders within biotech, pharma, diagnostics and medtech/health devices.
The BioStock Life Science Summit takes place during two days dedicated entirely to financing, partnering and deal making, offering a comprehensive 360 degree perspective on the capitalization climate within the Nordic life science sector. It features showcases from leading private and listed startups and growth stage companies. The program also includes thought provoking panel discussions with leading VCs, portfolio managers and capital raising experts, sharing crucial insights on attracting capital. It is a must-attend for any serious investor or startup, early stage or maturing company C-level executive looking for a competitive edge.
The regions top startup- and growth stage companies covering a number of therapeutic areas get the opportunity to pitch to and mingle with industry experts, talent scouts and business developers from global industry leaders within biotech and pharma.
The line-up features a number of Big Pharma companies presenting their respective start up- and partnering programs, as well as live interviews with key opinion leaders and industry executives – get ready for two days packed with business opportunities and unique insights into the financing and partnering processes.
Register today to secure your place among the top minds of the industry at the life science event of the year!
The main goal of the BioStock Life Science Summit is to bring together life science innovation with investors interested in the Nordic life science scene and potential scientific or commercial partners. Reaching that goal, the 2019 event featured a large number of small to medium-sized Nordic pharma, biotech, medical device and diagnostics companies and startups who's executive management and business development rep's presented to investors and Big Pharma during the two days of the event.
Showcase videos can be viewed by clicking the respective company's (underlined) name below.
A SELECTION OF THE +250 COMPANIES, INVESTORS & FINANCING EXPERTS WHO ATTENDED THE BIOSTOCK LIFE SCIENCE SUMMIT IN 2019:
Johnson & Johnson
Swedbank Robur Medica
Danske Bank Asset Management
European Investment Bank
Consensus asset management
ABG Sundal Collier
Erik Penser Bank
DeBere Capital Partners
What is BioStock?
BioStock is the Nordic region's leading digital news and analytics service focusing exclusively on the life science sector. By webcasting the BioStock Life Science Summit live via our multi-channel media platform and extensive media partner network, the presentations, panel discussions and industry insights will be reaching thousands of professional and retail investors in Sweden as well as internationally.
Our daily news briefings are closely monitored by a majority of life science executives in the Nordic region.
To learn more about BioStock, feel free to explore our content at biostock.se.
The annual BioStock Life Science Summit, which successfully debuted in 2018, attracted more than 250 guests during two days in 2019. The Summit is unique in that it not only gives companies a platform to showcase their projects and pitch them to investors. It is also an educational forum for companies looking to raise capital and/or reach a partnership as investors and potential partners share insights, experiences and strategies.
This year's event featured a number of thought provoking panel sessions on the subjects of investments, financing and partnering, which can all be viewed below.
Investor Insights – in search of the next Nordic unicorn
The first panel discussion at BioStock Life Science Summit 2019 featured representatives from major investors in the Nordics such as Björn Odlander from HealthCap, Ingrid Teigland Akay from Hadean Ventures, Johan Kördel from Lundbeckfonden Ventures, along with biotech entrepreneur Carl Borrebaeck from Lund University.
Investing in Innovations – from discovery to market
The second panel discussion at BioStock Life Science Summit 2019 featured Mattias Häggblom from Swedbank Robur Medica, Daniel Bolanowski from Arctic Aurora LifeScience, and Claus Johansen from Danske Bank Asset Management whom gave their expert insights on what fundmanagers look for before they decide to invest.
(Re)fueling the unique Nordic ecosystem – corporate finance & capital raise insights
Financial advisors Benjamin Nordin from ABG Sundal Collier, Jonas Ljungström from Naventus, Kristofer Krolak from Vator Securities, and Stefan Lundberg from Erik Penser Bank all gave their expert insights on capital raising and corporate finance, including giving advice to early stage companies looking to go public.
Industry insights – Partnering in the Nordic region
BioStock Life Science Summit was also a great opportunity for small pharma and medtech companies to meet and discuss potential partnership deals with Big Pharma. This panel session featured Anna Gran from Johnson & Johnson Innovation, Ralf W. Ackermann from Bayer Pharmaceutical, and Åsa Sjöholm-Timén from AstraZeneca shared their view on what big pharma players are looking for in potential partners.
Key learnings from entering a Big Pharma partnership
The final panel of the Summit event focused on lessons learned from past partnerships. Here, AstraZenca and Bayer were joined by representatives of two companies with partnership experience with the respective pharma giants: OnDosis and Pilloxa, in a panel featuring Jan Børge Jakobsen from Bayer Pharmaceutical, Per Nilsson from Pilloxa, Kay Brickmann from AstraZeneca, and Martin Olovsson from OnDosis, whom all shared their partnering experiences from different perspectives..